# Thomas Ebeling

> Thomas Ebeling is a seed investor at ProSiebenSat.1 Media backing Database and Health Care. See 2 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Fund: [ProSiebenSat.1 Media](https://shizune.co/investors/profile/prosiebensat1)
- Location: Boston, United States
- Total investments: 2
- Last investment: Jul 2024
- Lead investor: 0%
- Last updated: Aug 2026
- Website: http://www.mpmcapital.com/#team

Thomas Ebeling is a seed investor at ProSiebenSat.1 Media in Boston focused on Database and Health Care. Thomas Ebeling a standing member of OIF’s MSAB. After earning a degree in psychology in Hamburg, Thomas, began his career with Reemtsma in 1987, where he served as the product manager responsible for the “West” brand, among other duties. In 1991, he switched to Pepsi-Cola Germany, where he served as a marketing manager. In 1993, he was appointedMarketing Director for the entire beverage portfolio. Starting in 1994, he was National Sales and Franchise Director for the retail and restaurant sales of Pepsi-Cola. In 1996, he was appointed General Manager of Pepsi-Cola Germany. In 1997, he switched to Novartis, where he served as General Manager of Novartis Nutrition for Germany and Austria. In 1998, Thomas Ebeling assumed worldwide leadership of the Novartis Nutrition Division. In this position, he headed the three business units Medical Nutrition, Health Nutrition and Consumer Retail Brands, where, among other duties, he was responsible for the leading U.S. baby food brand Gerber. In 1998, he was appointed to the Novartis Executive Committee. From 2000 to October 2007, he served as CEO of the global Novartis pharmaceuticals business. Under his leadership, the company’s revenues more than doubled from US$11 billion to US$22.6 billion. In October 2007, he was appointed CEO of the Novartis Consumer Health Division. Since March 2009, he is CEO of ProSiebenSat.1 Media SE. Since 2012 Thomas Ebeling has been member of the supervisory board of Bayer AG and since 2013 he has been member of the board of directors of Lonza AG.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Database | 1 | 50% |
| Health Care | 1 | 50% |
| Biotechnology | 1 | 50% |
| Data Center Automation | 1 | 50% |
| Information Technology | 1 | 50% |

6 industries tracked in total.

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| ImmuneAGE Bio | ImmuneAGE Bio is an intriguing initiative focused on drug discovery for immune system rejuvenation. Developing therapies that can rejuvenate or enhance the immune system could have profound implications for healthcare, especially in aging populations or those with compromised immune function | $2M | Seed | Jul 11, 2024 |  |
| Elicit | Elicit is an artificial intelligence research assistant that uses language models to help users automate research workflows. This research assistant finds relevant papers without a perfect keyword match, summarizes takeaways from the papers, and extracts key information from the papers. | $9M | Seed | Sep 25, 2023 |  |

2 of 2 investments shown.

## Co-investors
- [1517 Fund](https://shizune.co/investors/profile/1517-fund) — VC Fund, 1 deal together
- [Basis Set Ventures](https://shizune.co/investors/profile/basis-set-ventures) — VC Fund, 1 deal together
- [Emerging Longevity Ventures](https://shizune.co/investors/profile/emerging-longevity-ventures) — VC Fund, 1 deal together
- [Fifty Years](https://shizune.co/investors/profile/fifty-years) — VC Fund, 1 deal together
- [Healthspan Capital](https://shizune.co/investors/profile/healthspan-capital) — VC Fund, 1 deal together
- [Illusian Founder Office](https://shizune.co/investors/profile/illusian-family-office) — VC Fund, 1 deal together

## About ProSiebenSat.1 Media

VC Fund · Unterföhring, Germany

ProSiebenSat.1 Media SE is a German mass media company operating television, radio stations and print businesses. The ProSiebenSat.1 Group is one of the largest independent media corporations in Europe with a reported reach of 42 million household around Europe. The company operates 15 television stations across Germany, Austria and Switzerland.ProSiebenSat.1 Media SE was established in 2000, with its headquarters in Unterföhring, Germany.

5 contacts available at ProSiebenSat.1 Media.

| Name | Title | Profile |
| --- | --- | --- |
| Philipp Meixner | Investment Director | https://shizune.co/investors/profile/philipp-meixner |
| Thomas Ebeling | Chairman of the Executive Board | https://shizune.co/investors/profile/thomas-ebeling-2 |
| Conrad Albert | Deputy-CEO, Group General Counsel | https://shizune.co/investors/profile/conrad-albert-e890 |
| Gerald Madlmayr | Performance Manager | https://shizune.co/investors/profile/gerald-madlmayr |
| Maximilian Conze | CEO | https://shizune.co/investors/profile/maximilian-conze |

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

## FAQ

### What does Thomas Ebeling invest in?

Thomas Ebeling invests primarily in Database, Health Care and Biotechnology startups, most often at Seed stage. Most of the 2 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Thomas Ebeling last invest?

The most recent investment recorded for Thomas Ebeling closed in Jul 2024. Shizune tracks 2 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co